Sergio Quiroz-Gomez

Dr. Sergio Quiroz-Gomez

División Académica de Ciencias de la Salud, Universidad Juárez Autónoma de Tabasco, Villahermosa, Tabasco, Mexico
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
JVJesús Maximiliano Granados Villalpando
Jesús Maximiliano Granados Villalpando
STSergio de Jesus Romero Tapia
Sergio de Jesus Romero Tapia
GFGuadalupe del Carmen Baeza Flores
Guadalupe del Carmen Baeza Flores
JCJorge Luis Ble Castillo
Jorge Luis Ble Castillo
IJIsela Juarez-Rojop
Isela Juarez-Rojop
Crystell Guadalupe Guzmán PriegoCrystell Guadalupe Guzmán Priego
Crystell Guadalupe Guzmán Priego
Vaccinations have helped to control the COVID-19 pandemic; however, few studies focus on the adverse effects and allergic reactions of these vaccines and fewer have a scope in the Latin American population. The objective of this study was to assess the associations between vaccinations, sex, age, allergic reactions, and adverse effects. This was an analytical cross-sectional study conducted between 1 July and 1 October 2022. The sample consisted of 443 surveyed participants, with a total of 1272 COVID-19 vaccine doses. Seven vaccines (Pfizer BioNTech, Oxford-AstraZeneca, CanSino, Moderna, Johnson and Johnson, Sinovac, and Sputnik V) were evaluated. A total of 12.6% of those surveyed had at least one allergic reaction posterior to vaccination, and females had a greater chance of developing one (p < 0.001, OR 3.1). The most common allergic reaction was chest pain, and Pfizer-BioNTech and Oxford-AstraZeneca were associated with the onset of allergic reactions (p < 0.005). A total of 54.6% of those surveyed developed adverse effects, the most common of which were myalgia, fever, cephalea, asthenia or adynamia, and arthralgia; moreover, older age was associated with the onset of adverse effects (p < 0.5). This study concludes that the BNT162b2 (Pfizer BioNTech) and ChAdOX1 nCOV-19 (Oxford-AstraZeneca) vaccines are strongly associated with the onset of allergic reactions, with ORs of 1.6 (CI 95%, 1.18 to 2.3) and 1.87 (CI 95%, 1.35 to 2.6), respectively. In addition, females have a greater chance of developing allergic reactions associated with COVID-19 vaccinations, and there was a relation found between older age and a greater prevalence of comorbidities, adverse effects after vaccination, and COVID-19 infection after vaccination.

JVJesús Maximiliano Granados Villalpando
Jesús Maximiliano Granados Villalpando
GFGuadalupe del Carmen Baeza Flores
Guadalupe del Carmen Baeza Flores
JBJorge Ble-Castillo
Jorge Ble-Castillo
KMKarla del Socorro Celorio Méndez
Karla del Socorro Celorio Méndez
IJIsela Juarez-Rojop
Isela Juarez-Rojop
Crystell Guadalupe Guzmán PriegoCrystell Guadalupe Guzmán Priego
Crystell Guadalupe Guzmán Priego
Mental health disorders are relatively common in the general population and were already an important issue for the healthcare sector before COVID-19. COVID-19, being a worldwide crucial event and evidently a great stressor has increased both the prevalence and incidence of these. Therefore, it is evident that COVID-19 and mental health disorders are closely related. Moreover, several coping strategies exist to endure said disorders such as depression and anxiety, which are used by the population to confront stressors, and healthcare workers are not the exception. This was an analytical cross-sectional study, conducted from August to November 2022, via an online survey. Prevalence and severity of depression, anxiety, and stress were assessed via the DASS-21 test, and coping strategies were assessed via the CSSHW test. The sample consisted of 256 healthcare workers and of those, 133 (52%) were males with a mean age of 40.4 ± 10.35, and 123 (48%) were females with a mean age of 37.28 ± 9.33. Depression was prevalent in 43%, anxiety in 48%, and stress in 29.7%. Comorbidities were a significant risk factor for both depression and anxiety with an OR of 10.9 and 4.18, respectively. The psychiatric background was a risk factor for depression with an OR of 2.17, anxiety with an OR of 2.43, and stress with an OR of 3.58. The age difference was an important factor in the development of depression and anxiety. The maladaptive coping mechanism was prevalent in 90 subjects and was a risk factor for depression (OR of 2.94), anxiety (OR of 4.46) and stress (OR of 3.68). The resolution coping mechanism was a protective factor for depression (OR of 0.35), anxiety (OR of 0.22), and stress (OR of 0.52). This study shows that mental health disorders are highly prevalent among healthcare workers in Mexico and that coping strategies are associated with their prevalence. It also implies that not only occupations, age, and comorbidities might affect mental health, but also the way patients confront reality and the behavior and decisions they take towards stressors.

JAJesús Josué Cárdenas Anguiano
Jesús Josué Cárdenas Anguiano
SQSergio Quiroz-Gomez
Sergio Quiroz-Gomez
Crystell Guadalupe Guzmán PriegoCrystell Guadalupe Guzmán Priego
Crystell Guadalupe Guzmán Priego
KMKarla del Socorro Celorio Méndez
Karla del Socorro Celorio Méndez
MBManuel Alfonso Baños-González
Manuel Alfonso Baños-González
JMJorda Albarrán Melzer
Jorda Albarrán Melzer
Introduction: The burden of disease measures the total impact of diseases on a population, considering incidence, prevalence, disability, and premature mortality. This study analyzes the burden of ischemic heart disease (IHD) in Tabasco, Mexico, from 2013 to 2021. Ischemic heart disease has a significant incidence of 21,203,479 cases worldwide, and nationally (inside Mexico) a total of 221,747 cases, with more than 9,137,791 deaths due to this pathology globally. Objective: To analyze the burden of ischemic heart disease in Tabasco, Mexico, during the 2013–2021 period. Methods: An observational, descriptive, longitudinal, and retrospective study was conducted in Tabasco. The study population consisted of 2,402,598 people according to INEGI, with a sample of 927,000 adults (462,000 men and 465,000 women). Data were used from the General Directorate of Health Information, IHME, and the World Bank. Analyses were performed in Microsoft Excel, calculating measures of central tendency, dispersion, and Disability-Adjusted Life Years (DALYs). Results: The DALYs in the adult population of Tabasco were: 2013—23,932; 2014—28,132; 2015—30,197; 2016—30,683; 2017—31,839; 2018—38,599; 2019—40,046; 2020—42,307; and 2021—55,723, totaling 297,576 DALYs from 2013 to 2021. Discussion: Ischemic heart disease increased in incidence and mortality in both men and women during the years analyzed. The increase in DALYs indicates a greater impact of ischemic heart disease in Tabasco compared to countries like Costa Rica. Conclusion: The burden of ischemic heart disease from 2013 to 2021 represents a significant loss of quality and years of life in the population of Tabasco, Mexico.

28 February 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
CPCrystell Guadalupe Guzman Priego
Crystell Guadalupe Guzman Priego
JVJesús Maximiliano Granados Villalpando
Jesús Maximiliano Granados Villalpando
GFGuadalupe del Carmen Baeza Flores
Guadalupe del Carmen Baeza Flores
JCJorge Luis Ble Castillo
Jorge Luis Ble Castillo
KMKarla del Socorro Celorio Méndez
Karla del Socorro Celorio Méndez
KAKatia Amairani Jiménez Aragón
Katia Amairani Jiménez Aragón
Background: Persistent cognitive and neuropsychiatric symptoms have been increasingly reported as part of the post-COVID-19 condition. Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) are circulating biomarkers of neuronal and astrocytic injury that increase during acute SARS-CoV-2 infection; however, their role in long-term neuropsychiatric sequelae remains unclear. Objective: To provide a narrative overview of cognitive and neuropsychiatric sequelae following SARS-CoV-2 infection and to explore the association of plasma NfL and GFAP concentrations with cognitive impairment and neuropsychiatric symptoms in individuals recovered from COVID-19. Methods: A narrative review of the literature was conducted, followed by an exploratory cross-sectional study including 41 adults recovered from SARS-CoV-2 infection. Participants were classified according to acute disease severity into two groups. Cognitive function was assessed using MoCA, and neuropsychiatric symptoms were evaluated using DASS-21. Plasma NfL and GFAP concentrations were measured by ELISA. Group comparisons and Spearman correlation analyses were performed. Results: A total of 41 individuals were studied; they recovered from moderate or severe COVID-19 and exhibited a higher prevalence of cognitive impairment and neuropsychiatric symptoms compared with those who recovered from mild or asymptomatic infection. Plasma NfL and GFAP concentrations did not differ significantly between severity groups. NfL showed a weak association with the presence of post-COVID-19 condition. Conclusions: This study highlights the high burden of persistent cognitive and neuropsychiatric symptoms following moderate and severe SARS-CoV-2 infection. The absence of sustained elevations in circulating NfL and GFAP nearly two years after infection suggests that ongoing symptoms may involve mechanisms beyond overt neuronal or astrocytic injury.

31 January 2022 in American Journal of Health Behavior
Verified
Journal Article
Open access
SQSergio Quiroz-Gomez
Sergio Quiroz-Gomez
MGMarisol Guzman-Moreno
Marisol Guzman-Moreno
ACArmando Miranda-De La Cruz
Armando Miranda-De La Cruz
JGJanett Marina Garcia-Hernandez
Janett Marina Garcia-Hernandez
KAKarina del Carmen Arcos-Castillo
Karina del Carmen Arcos-Castillo
JCJairo David Contrera-Madrigal
Jairo David Contrera-Madrigal
Objectives: In this study, we identify knowledge, attitudes, and practices (KAPs) of the people of the State of Tabasco (Mexico) as they influence transmission and mitigation of COVID-19. Methods: We used an Internet-based survey (N=1848) from March to July 2021, with a probabilistic sampling stratified by municipalities. Results: Most respondents demonstrated knowledge about the etiology and symptoms of COVID-19 – they assume that anyone can contract the disease, and at least 53.5% knew that the cause is a virus. They believed that it constitutes a problem for their community due to its easy transmission; however, they consider themselves to be only at medium risk. They have adopted preventive measures such as handwashing, staying home, and social distancing; however, when analyzing protecting the community, they refer to other people as having responsibility for preventing disease spread. Conclusions: Interventions focused on social and cultural contexts are required. Sociodemographic and ideological factors influence disinformation, limited interventions, and cognitive dissonance. This type of research contributes to discovering areas of opportunity for government and public health organizations to prioritize practical actions and reduce eventual outbreaks.

30 November 2019 in European Scientific Journal ESJ
Verified
Journal Article
Open access
PDF file
LSLuis Ricardo Palmer Serrano
Luis Ricardo Palmer Serrano
SQSergio Quiroz-Gomez
Sergio Quiroz-Gomez
MMMarisol Guzmán Moreno
Marisol Guzmán Moreno
Efectividad de Intervención Educativa Para la Aceptación del Suplemento “Vita Niño” en Madres Beneficiarias del Programa PROSPERA